Role of Glucagon-Like Peptide 1 Receptor Agonists in Management of Obesity
including semaglutide branded as Wegovy or Ozempic, and tirzepatide (dual GIP/GLP-1 receptor agonist) branded as Zepbound or Mounjaro, for the management of obesity, type 2 diabetes, and other metabolic conditions increases, so too does the need to assess the advantages and potential downsides of long-term use
Platelet-rich plasma: from basic science to clinical applications
FIGURE 1 2 Molecular mechanism of GLP-1RA in the eye At the same time, as the pleiotropic effects of GLP-1RAs are gradually exhibited, their molecular mechanism, besides lowering blood glucose, is gaining increasing attention
The side effects were so bad she was vomiting multiple times a week, and she still didnt want to stop
E3S Web Conf 07011